Peripheral lung adenocarcinomas: 10 mm or less in diameter

被引:38
作者
Kondo, D
Yamada, K
Kitayama, Y
Hoshi, S
机构
[1] Shizuoka Saiseikai Gen Hosp, Dept Gen Thorac Surg, Shizuoka 4228021, Japan
[2] Shizuoka Saiseikai Gen Hosp, Dept Pathol, Shizuoka, Japan
关键词
D O I
10.1016/S0003-4975(03)00340-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Few reports have been published regarding peripheral lung adenocarcinomas that are 10 mm or less in diameter. This is considered to be the smallest tumor size detectable by present diagnostic modalities. Methods. Clinicopathologic studies were performed in 57 patients with peripheral lung adenocarcinomas of 10 mm or less in diameter. Outcomes were compared with two other groups that consisted of 32 patients with adenocarcinomas between 11 and 15 nun in diameter and 35 patients with adenocarcinomas between 16 and 20 mm in diameter. Tumors were curatively resected between 1992 and 2002. Results. The mean age was 61.7 years. The following three features were more frequent: female sex (78.9%), nonsmokers (77.2%), and cases with carcinoma detected by computed tomography despite negative chest radiography (96.5%). Negative lymphatic invasion (94.7%) was significantly higher. Three cases showed lymphatic invasion that was classified as types E or F, according to Noguchi's classification. There were no cases of lymph node metastasis, pleural involvement, or intrapulmonary metastasis. Well-differentiated type was in 93.0%. Types A and B, which are noninvasive alveolar replacement-type adenocarcinomas, were significantly dominant (86.0%). The 5-year postoperative survival rate was 97.3%, which was significantly better than in the other two groups (75.5%, 78.1%). Conclusions. Histopathologic features of most peripheral lung adenocarcinomas of 10 mm or less. in diameter were types A and B. Types A and B were considered fundamentally indicated for thoracoscopic wedge resections. However, the other types required the standard operation. (C) 2003 by The Society of Thoracic Surgeons.
引用
收藏
页码:350 / 355
页数:6
相关论文
共 27 条
[11]  
NAKAMURA M, 1986, LUNG CANCER, V26, P137
[12]  
NARUKE T, 1978, J THORAC CARDIOV SUR, V76, P832
[13]  
NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO
[14]  
2-#
[15]  
PASTORINO U, 1991, EUR J SURG ONCOL, V17, P42
[16]   SURVIVAL AFTER CONSERVATIVE RESECTION FOR T1-N0-M0 NON-SMALL-CELL LUNG-CANCER [J].
READ, RC ;
YODER, G ;
SCHAEFFER, RC .
ANNALS OF THORACIC SURGERY, 1990, 49 (03) :391-400
[17]   RISK OF LUNG-CANCER AMONG CIGARETTE SMOKERS IN RELATION TO TUMOR LOCATION [J].
SHIMIZU, H ;
NAGATA, C ;
TSUCHIYA, E ;
NAKAGAWA, K ;
WENG, SY .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (12) :1196-1199
[18]  
SOBIN LH, 1997, INT UNION AGAINST CA
[19]   Mass screening for lung cancer with mobile spiral computed tomography scanner [J].
Sone, S ;
Takashima, S ;
Li, F ;
Yang, ZG ;
Honda, T ;
Maruyama, Y ;
Hasegawa, M ;
Yamanda, T ;
Kubo, K ;
Hanamura, K ;
Asakura, K .
LANCET, 1998, 351 (9111) :1242-1245
[20]   Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma [J].
Suzuki, K ;
Nagai, K ;
Yoshida, J ;
Nishimura, M ;
Nishiwaki, Y .
ANNALS OF THORACIC SURGERY, 2001, 72 (02) :352-356